Cytovia Therapeutics has found an “ISLE” to dock at in the choppy waters of biotech public markets. The natural killer (NK) cell startup is set to merge with a special purpose acquisition company (SPAC) to secure the cash to enter the clinic and try to get through to a data drop in 2024. Isleworth Healthcare Acquisition Corp. […]

A first healthy volunteer has been enrolled in a Phase 1 trial and given a first dose of PrimeC, an investigational combination therapy for people with amyotrophic lateral sclerosis (ALS), the treatment’s developer, NeuroSense Therapeutics, announced. The open-label Phase 1 trial (NCT05232461) is a pharmacokinetic study, or one that evaluates how a treatment moves into, through, and out of […]

Prescription digital therapeutics providers (PDTs) have been pushing for recognition and acceptance in the health care sector for years. That effort got a major boost thanks to a seemingly minor administrative move from the federal government. In February, the Centers for Medicare & Medicaid Services (CMS) announced the creation of a new reimbursement code for […]